David W Meline - Net Worth and Insider Trading
David W Meline Net Worth
The estimated net worth of David W Meline is at least $15 Million dollars as of 2024-11-13. David W Meline is the EVP & CFO of Amgen Inc and owns about 49,378 shares of Amgen Inc (AMGN) stock worth over $15 Million. David W Meline is the CFO of Moderna Inc and owns about 2,857 shares of Moderna Inc (MRNA) stock worth over $124,194. David W Meline is also the Director of Pacific Biosciences of California Inc and owns about 40,000 shares of Pacific Biosciences of California Inc (PACB) stock worth over $88,000. Besides these, David W Meline also holds 3M Co (MMM) . Details can be seen in David W Meline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David W Meline has not made any transactions after 2024-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David W Meline
David W Meline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David W Meline owns 5 companies in total, including Moderna Inc (MRNA) , Amgen Inc (AMGN) , and 3M Co (MMM) among others .
Click here to see the complete history of David W Meline’s form 4 insider trades.
David W Meline Latest Holdings Summary
David W Meline currently owns a total of 4 stocks. Among these stocks, David W Meline owns 49,378 shares of Amgen Inc (AMGN) as of November 25, 2019, with a value of $15 Million and a weighting of 98.58%. David W Meline owns 2,857 shares of Moderna Inc (MRNA) as of August 10, 2022, with a value of $124,194 and a weighting of 0.83%. David W Meline also owns 40,000 shares of Pacific Biosciences of California Inc (PACB) as of March 6, 2024, with a value of $88,000 and a weighting of 0.59%. The other 1 stocks 3M Co (MMM) have a combined weighting of 0% among all his current holdings.
Latest Holdings of David W Meline
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMGN | Amgen Inc | 2019-11-25 | 49,378 | 298.84 | 14,756,122 |
MRNA | Moderna Inc | 2022-08-10 | 2,857 | 43.47 | 124,194 |
PACB | Pacific Biosciences of California Inc | 2024-03-06 | 40,000 | 2.20 | 88,000 |
MMM | 3M Co | 2013-10-29 | 0 | 130.35 | 0 |
Holding Weightings of David W Meline
David W Meline Form 4 Trading Tracker
According to the SEC Form 4 filings, David W Meline has made a total of 1 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amgen Inc is the sale of 8,737 shares on November 25, 2019, which brought David W Meline around $2 Million.
According to the SEC Form 4 filings, David W Meline has made a total of 3 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Moderna Inc is the sale of 164 shares on August 10, 2022, which brought David W Meline around $28,480.
According to the SEC Form 4 filings, David W Meline has made a total of 1 transactions in Pacific Biosciences of California Inc (PACB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pacific Biosciences of California Inc is the acquisition of 40,000 shares on March 6, 2024, which cost David W Meline around $176,000.
More details on David W Meline's insider transactions can be found in the Insider Trading History of David W Meline table.Insider Trading History of David W Meline
- 1
David W Meline Trading Performance
GuruFocus tracks the stock performance after each of David W Meline's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David W Meline is -50.9%. GuruFocus also compares David W Meline's trading performance to market benchmark return within the same time period. The performance of stocks bought by David W Meline within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David W Meline's insider trading performs compared to the benchmark.
Performance of David W Meline
David W Meline Ownership Network
Ownership Network List of David W Meline
Ownership Network Relation of David W Meline
David W Meline Owned Company Details
What does Moderna Inc do?
Who are the key executives at Moderna Inc?
David W Meline is the Chief Financial Officer of Moderna Inc. Other key executives at Moderna Inc include President Stephen Hoge , Chief Financial Officer James M Mock , and Chief Legal Officer Shannon Thyme Klinger .
Moderna Inc (MRNA) Insider Trades Summary
Over the past 18 months, David W Meline made no insider transaction in Moderna Inc (MRNA). Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 802,832 shares made by Noubar Afeyan , a net sale of 200,218 shares made by Stephen Hoge , and a net sale of 12,167 shares made by Shannon Thyme Klinger .
In summary, during the past 3 months, insiders sold 5,239 shares of Moderna Inc (MRNA) in total and bought 0 shares, with a net sale of 5,239 shares. During the past 18 months, 1,560,978 shares of Moderna Inc (MRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,560,978 shares.
Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Moderna Inc Insider Transactions
David W Meline Mailing Address
Above is the net worth, insider trading, and ownership report for David W Meline. You might contact David W Meline via mailing address: 3m Company, 3m Office Of General Counsel, St Paul Mn 55144-1000.